Financing: Page 2

Pattern Bioscience raises $28.7M in Series C financing to develop, commercialize rapid test platform for infectious diseases

Pattern Bioscience said it will use the funds to complete the development of its infectious disease diagnostic platform, perform validation studies, and submit data for the platform and the company’s initial test for pneumonia for FDA review.

April 27, 2023

CND Life Sciences closes $4.5M seed financing round

The funding is intended to accelerate the commercialization of the Syn-One test that identifies abnormal alpha-synuclein aggregation in cutaneous nerves through a skin biopsy.

April 6, 2023

Alzheimer’s disease testing firm C2N nabs additional $15M in financing

C2N will allocate part of the additional financing to support its new generation blood test, PrecivityAD2, designed to aid in the diagnosis of Alzheimer's disease.

February 17, 2023

Simple HealthKit closes $8M in Series A financing

The Fremont, CA-based company said that its product portfolio includes diagnostic tests for sexual health, chronic conditions such as diabetes, and the tripledemic of COVID-19, respiratory syncytial virus (RSV), and influenza A and B.

February 6, 2023

HTG Molecular Diagnostics prices $10M public offering

HTG uses transcriptome-wide profiling for translational research, novel therapeutics, and clinical diagnostics across a variety of disease areas.

December 22, 2022

Avalon GloboCare announces $4M private placement of shares to support Laboratory Services MSO acquisition

The proceeds will be used toward the purchase of Laboratory Services MSO, in Costa Mesa, CA. Avalon announced in early November its acquisition of a 60% interest in Laboratory Services MSO.

December 14, 2022

Pictor launches $5M financing round to support product, market development

Pictor's multiplex technology enables testing for multiple diseases or different stages of a disease within a single enzyme-linked immunosorbent assay (ELISA) test well.

December 5, 2022

PictorLabs closes $15.2M financing to develop AI-based virtual staining platform

With the additional funds secured in the latest round of financing, PictorLabs intends to expand its biomarker portfolio and develop its products.

December 1, 2022

Sherlock Biosciences secures funding to further develop CRISPR testing platform

The company said it will use the funding to further develop its CRISPR testing platform, enabling broader testing in low- and middle-income countries.

November 29, 2022

Empatica receives FDA clearance for digital biomarker platform, closes Series B financing

The platform is used to gather and analyze physiological data for clinical trials evaluating new therapeutics. Empatica is collaborating with researchers on digital biomarkers for use as endpoints.

November 23, 2022

Biodesix secures loan of up to $50M, announces $35.1M stock offering

The developer of diagnostic tests that combine multiomics through AI said it will use the loan to strengthen its balance sheet, reduce near-term cash use, and enable the continued growth trajectory of its core lung diagnostics business.

November 17, 2022

SQI Diagnostics secures C$2M to support manufacturing, commercialization

SQI will use the funds to support its manufacturing scale-up and commercialization of its pipeline of products in development, including the Rali-Dx IL-6 test.

November 10, 2022

Previous Page

Page 2 of 6

Next Page